Overview

A Randomized, Open Label, Prospective Study to Explore the Clinical Characteristics of Oral MNK155 and Norco 7.5mg/325 When Used for the Treatment of Moderate to Severe Post Operative Pain

Status:
Terminated

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to explore the clinical characteristics oral MNK155 and Norco® 7.5mg/325mg when used for the treatment of moderate to severe post operative pain.

Phase:

Phase 3

Details

Lead Sponsor:

Neil Singla

Collaborator:

Mallinckrodt

Treatments:

Acetaminophen, hydrocodone drug combination